Skip to main content
Clinical Trials/NCT04783155
NCT04783155
Recruiting
N/A

Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant: A Randomized Controlled Trial

Mayo Clinic1 site in 1 country30 target enrollmentMay 10, 2021

Overview

Phase
N/A
Intervention
POWERBreathe Plus®
Conditions
Post-Lung Transplantation Bronchiectasis
Sponsor
Mayo Clinic
Enrollment
30
Locations
1
Primary Endpoint
Maximal inspiratory mouth pressure (MIP) measured in cmH2O
Status
Recruiting
Last Updated
3 months ago

Overview

Brief Summary

The purpose of this research is to study the effect of training the inspiratory muscles (i.e. the muscle that allow you to breath-in) on exercise capacity, quality of life, and short-term clinical outcomes in patients post lung transplant.

Registry
clinicaltrials.gov
Start Date
May 10, 2021
End Date
December 1, 2027
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Bryan Taylor

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • \- All patients who undergo single- or double-lung transplant at Mayo Clinic Florida.

Exclusion Criteria

  • Patients who do not survive the intra-operative period during the transplant surgery.
  • Patients undergoing retransplantation.
  • Patients undergoing multiorgan transplantation.
  • Patients who are not willing to or who are unable to give written informed consent.

Arms & Interventions

12-weeks pulmonary rehabilitation training plus inspiratory muscle training

To assess maximum inspiratory pressure, you will be asked to breathe through a device called POWERBreathe Plus®. This device is commercially available and will be provided to you by the study. You will be asked to use this device twice per day, 5 days per week, for 12 weeks. Each session will require you to breathe into the device 30 times. You can use the device at home.

Intervention: POWERBreathe Plus®

12-weeks pulmonary rehabilitation training plus inspiratory muscle training

To assess maximum inspiratory pressure, you will be asked to breathe through a device called POWERBreathe Plus®. This device is commercially available and will be provided to you by the study. You will be asked to use this device twice per day, 5 days per week, for 12 weeks. Each session will require you to breathe into the device 30 times. You can use the device at home.

Intervention: Cardiopulmonary rehabilitation post lung transplant

12-weeks pulmonary rehabilitation plus placebo (inactive) inspiratory muscle

To assess maximum inspiratory pressure with placebo, you will be asked to breathe through a device called POWERBreathe Plus®. This device is commercially available and will be provided to you by the study. You will be asked to use this device twice per day, 5 days per week, for 12 weeks. Each session will require you to breathe into the device 30 times. You can use the device at home. The resistance will be set to about 5% throughout the study.

Intervention: POWERBreathe Plus®

12-weeks pulmonary rehabilitation plus placebo (inactive) inspiratory muscle

To assess maximum inspiratory pressure with placebo, you will be asked to breathe through a device called POWERBreathe Plus®. This device is commercially available and will be provided to you by the study. You will be asked to use this device twice per day, 5 days per week, for 12 weeks. Each session will require you to breathe into the device 30 times. You can use the device at home. The resistance will be set to about 5% throughout the study.

Intervention: Cardiopulmonary rehabilitation post lung transplant

Outcomes

Primary Outcomes

Maximal inspiratory mouth pressure (MIP) measured in cmH2O

Time Frame: 12 weeks

The maximal strength generating capacity of the inspiratory muscles.

Secondary Outcomes

  • Maximal oxygen uptake (V̇O2max) measured in mL/kg/min(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials